Home › Therapeutic areas › Renal › Chronic Kidney Disease
Chronic Kidney Disease (6 companies)
Companies with an active program in Chronic Kidney Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics | HematologyOphthalmology+2 Rare | 1 | Approved | $111M | 10 |
| ARDX | Ardelyx | GI/HepatologyRenal | 1 | Approved | $724M | 4 |
| IRON | Disc Medicine | GI/HepatologyHematology+2 Rare | 1 | Phase 3 | $3.59B | 9 |
| IONS | Ionis Pharmaceuticals | CardiovascularHematology+5 Rare | 1 | Approved | $6.55B | 29 |
| MAZE | Maze Therapeutics | MetabolicRenal Rare | 1 | Phase 2 | $1.90B | 4 |
| MLYS | Mineralys Therapeutics | CardiovascularRenal+1 | 1 | NDA Submitted | $1.36B | 3 |
No companies match.